Clinical trialNCT06669117RecruitingPhase 1/PHASE2Interventional

FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations

SponsorPierre Fabre MedicamentEnrollment140MET AlterationSolid Tumor

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium

Institut Jules Bordet
Anderlecht, Belgium
Recruiting

France

Aphp de Marseille - Hôpital Nord
Marseille, France
Laurent Greillier
Recruiting
Institut de Cancerologie de Ouest (ico) - Saint-Herblain
Saint-Herblain, France
Judith Raimbourg
Recruiting
Institut Universitaire Du Cancer de Toulouse - Oncopole
Toulouse, France
Julien Mazieres
Recruiting
Gustave Roussy
Villejuif, France
Recruiting

Germany

Universitaet Zu Koeln - Centrum Fuer Integrierte Onkologie (cio)
Cologne, Germany
Recruiting
Universitätsklinikum Carl Gustav Carus Dresden
Dresden, Germany
Martin Wermke
Recruiting

Italy

Azienda Ospedaliero - Universitaria San Luigi Gonzaga
Orbassano, Italy
Silvia Novello
Recruiting

Netherlands

Nederlands Kanker Instituut - Antoni Van Leeuwenhoek Ziekenhuis
Amsterdam, Netherlands
Gerrina Ruiter, MD, PhD
Recruiting

South Korea

Asan Medical Center (amc)
Seoul, South Korea
Dae Ho Lee, MD, PhD
Recruiting
Yonsei University College of Medicine
Seoul, South Korea
Sun Min Lim, MD, PhD
Recruiting

Spain

Hospital Universitario 12 de Octubre
Madrid, Spain
Luis Paz-Ares Rodriguez, MD, PhD
Recruiting
Hospital Universitario la Paz
Madrid, Spain
Francisco Javier de Castro Carpe
Recruiting

Taiwan

National Taiwan University Hospital
Taipei, Taiwan
Chia-Chi Lin, MD, PhD
Recruiting
Taipei Medical University Hospital
Taipei, Taiwan
Chao-Hua Chiu, MD
Recruiting
Taipei Veterans General Hospital
Taipei, Taiwan
Recruiting

United States

Georgetown Lombardi Comprehensive Cancer Center
Washington D.C., District of Columbia, United States
Chul Kim, MD
Recruiting
Gabrail Cancer Research Center
Canton, Ohio, United States
Nashat Gabrail, MD
Recruiting
Sarah Cannon Research Institute Oncology Partners
Nashville, Tennessee, United States
Meredith Ann McKean, MD, MPH
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 22 Oct 2024
Primary completion: 21 Oct 2030
Completion: 1 Oct 2032
Last update posted: 2 Jul 2025
Registered enrollment: 140
Registry id: NCT06669117

Cross-registrations

EU-CTR / CTIS (EudraCT)2024-512760-64-00

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.